Biologically Inspired Engineering, synbio, synthetic biology, crispr
NeuroBo Pharmaceuticals is a clinical stage drug development company with a focus on weight loss and a GLP-1 Dual Agonist. Its most advanced drug candidate, A-1726, is a novel oxyntomodulin analogue functioning as a GLP1R/GCGR dual agonist for the treatment of obesity. The IND approval is expected soon with Phase 1 trials commencing shortly thereafter. … Read more
Brad Loncar, Founder of BiotechTV, observed during an interview in October 2023 that some people were dressed as GLP-1 agonists for Halloween. He was interviewing Dr. Eric Topol, of Scripps Research Institute, who suggested they dress up as skeletons due to how little is known about the mode of action in this class of drugs … Read more
Investment banking giant Goldman Sachs is making a major move into the life sciences sector with the launch of its first-ever dedicated fund, West Street Life Sciences I. The $650 million fund signals Goldman’s confidence in the burgeoning field and its potential for significant returns despite a recent period of setback and gloom – and … Read more
U.S. pharmaceutical companies Moderna and Merck say a clinical trial for an experimental Moderna mRNA vaccine used in combination with the Merck cancer therapy drug Keytruda reduced the chance of recurrence or death from melanoma by nearly 50%. “As we continue to follow participants in the KEYNOTE-942/mRNA-4157-P201 study, we are excited to see such a … Read more
Intensity Therapeutics, Inc. is a clinical-stage biotechnology company applying scientific leadership in the field of localized cancer reduction leading to anti-cancer immune activation. The company’s approach involves the direct injection into tumors of a unique product created from its DfuseRx℠ discovery platform. Valuation/risk: According to Stifel, Phase 3 valuations are up 33% since … Read more
The field of gene editing has taken a leap forward with the recent approvals of two CRISPR-based drugs, Casgevy and Lyfgenia, for the treatment of sickle cell disease (SCD). These groundbreaking therapies offer potential for treating this previously incurable disease, generating excitement and hope for patients and the science around gene editing. The Money Pricing: … Read more
Ohalo Genetics is dedicated to accelerating the evolution of crops to create more efficient and sustainable agriculture. They use innovative plant genetic technologies to improve various aspects of crops, including: Yield: They aim to increase crop yields to meet the growing demand for food from a world population that is expected to reach 10 billion … Read more
Google Cloud recently announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. The Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and … Read more
Earlier this year, a Jefferies analyst quantified the market downturn in the biotechnology sector and came up with a number: 128 companies were trading at a market cap smaller than the cash they have on hand, representing 25% share. This rivals the severity of 2008-2009 period, where 15-20% of the industry was trading below cash. … Read more
There are 37 trillion or so cells in our bodies that work together to give us life. But it may surprise you that we still haven’t put a good number on how many distinct cell types there are within those trillions of cells. That’s why in 2016 a team of researchers from around the globe … Read more